Dysostosis Multiplex in Human Mucopolysaccharidosis Type 1 H and in Animal Models of the Disease

Area of Science:

• Genetics
• Biochemistry
• Skeletal Biology

Background:

• Mucopolysaccharidosis type I (MPS I) is a rare autosomal recessive disorder resulting from alpha-L-iduronidase deficiency.
• This deficiency leads to the accumulation of dermatan and heparan sulfates, causing a spectrum of disease severity.
• Dysostosis multiplex, a complex of skeletal abnormalities, is a key feature of severe MPS I (MPS-IH).

Purpose of the Study:

• To compare the manifestations of dysostosis multiplex in human patients with MPS-IH and in relevant animal models.
• To highlight species-specific differences in skeletal abnormalities observed in MPS-IH models.
• To emphasize the importance of considering these differences in disease research and diagnosis.

Main Methods:

• Retrospective review of clinical data from MPS-IH patients.
• Comparative analysis of skeletal abnormalities in dog, cat, and mouse models of MPS-IH.
• Evaluation of species-specific timing of skeletal manifestation onset.

Main Results:

• Animal models exhibit certain MPS-IH characteristics, but species-specific skeletal manifestations vary.
• The timing of skeletal abnormality emergence differs across species; for example, thoracolumbar kyphosis appears early in humans but late in mice.
• These variations necessitate careful consideration when interpreting findings from animal models.

Conclusions:

• Species-specific differences in dysostosis multiplex are crucial for understanding MPS-IH pathology.
• Careful selection of diagnostic tests and consideration of species-specific disease progression are vital for accurate research and clinical evaluation.
• Understanding these nuances improves the translational relevance of animal models in MPS-IH research.